Cancer Research Leaders Pin Hopes on Immune System and Early Detection
The TIME100 Health Leadership Forum in New York brought together leading experts in cancer research to reflect on significant strides made in tackling the disease. Shane Jacobson, CEO of both the American Cancer Society and its Cancer Action Network, attributed major breakthroughs to key resources. He noted that philanthropic investments and federal government funding have allowed scientists and oncologists to make progress in cancer prevention and treatment.
Cancer is a widespread issue, with one in three men and women in the US expected to receive a diagnosis sometime during their lives. Jacobson acknowledged its devastating impact: 'It has been, historically, such a devastating disease.' He emphasized that decades of research have led to developments like mRNA cancer vaccines announced by Moderna and Merck last month.
Dr. Andrea Cercek, a gastrointestinal medical oncologist at Memorial Sloan Kettering Cancer Center, highlighted the importance of harnessing the immune system through vaccines and immunotherapy. Her own pioneering work has shown promising results in treating rectal cancer with immunotherapy drugs.
Jacobson and Cercek expressed confidence that a cure for cancer will be found, but it's likely to involve early detection and prevention. Jacobson noted, 'It's not one cure, and we're seeing that now.'